Efficacy and safety of the use of omalizumab in a patient with difficult-to-control severe asthma and antiphospholipid antibody syndrome

Detalles Bibliográficos
Autores principales: Villela, Rosangela, Melo, Janaina M, Nociti, Thais, Araujo, Ana Carla S, Arruda, L Karla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2015
Materias:
Meeting Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407072/
http://dx.doi.org/10.1186/1939-4551-8-S1-A219
_version_ 1782367853813432320
author Villela, Rosangela
Melo, Janaina M
Nociti, Thais
Araujo, Ana Carla S
Arruda, L Karla
author_facet Villela, Rosangela
Melo, Janaina M
Nociti, Thais
Araujo, Ana Carla S
Arruda, L Karla
author_sort Villela, Rosangela
collection PubMed
description
format Online
Article
Text
id pubmed-4407072
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher World Allergy Organization
record_format MEDLINE/PubMed
spelling pubmed-44070722015-04-28 Efficacy and safety of the use of omalizumab in a patient with difficult-to-control severe asthma and antiphospholipid antibody syndrome Villela, Rosangela Melo, Janaina M Nociti, Thais Araujo, Ana Carla S Arruda, L Karla World Allergy Organ J Meeting Abstract World Allergy Organization 2015-04-08 /pmc/articles/PMC4407072/ http://dx.doi.org/10.1186/1939-4551-8-S1-A219 Text en Copyright © 2015 Villela et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Meeting Abstract
Villela, Rosangela
Melo, Janaina M
Nociti, Thais
Araujo, Ana Carla S
Arruda, L Karla
Efficacy and safety of the use of omalizumab in a patient with difficult-to-control severe asthma and antiphospholipid antibody syndrome
title Efficacy and safety of the use of omalizumab in a patient with difficult-to-control severe asthma and antiphospholipid antibody syndrome
title_full Efficacy and safety of the use of omalizumab in a patient with difficult-to-control severe asthma and antiphospholipid antibody syndrome
title_fullStr Efficacy and safety of the use of omalizumab in a patient with difficult-to-control severe asthma and antiphospholipid antibody syndrome
title_full_unstemmed Efficacy and safety of the use of omalizumab in a patient with difficult-to-control severe asthma and antiphospholipid antibody syndrome
title_short Efficacy and safety of the use of omalizumab in a patient with difficult-to-control severe asthma and antiphospholipid antibody syndrome
title_sort efficacy and safety of the use of omalizumab in a patient with difficult-to-control severe asthma and antiphospholipid antibody syndrome
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407072/
http://dx.doi.org/10.1186/1939-4551-8-S1-A219
work_keys_str_mv AT villelarosangela efficacyandsafetyoftheuseofomalizumabinapatientwithdifficulttocontrolsevereasthmaandantiphospholipidantibodysyndrome
AT melojanainam efficacyandsafetyoftheuseofomalizumabinapatientwithdifficulttocontrolsevereasthmaandantiphospholipidantibodysyndrome
AT nocitithais efficacyandsafetyoftheuseofomalizumabinapatientwithdifficulttocontrolsevereasthmaandantiphospholipidantibodysyndrome
AT araujoanacarlas efficacyandsafetyoftheuseofomalizumabinapatientwithdifficulttocontrolsevereasthmaandantiphospholipidantibodysyndrome
AT arrudalkarla efficacyandsafetyoftheuseofomalizumabinapatientwithdifficulttocontrolsevereasthmaandantiphospholipidantibodysyndrome

Ejemplares similares